These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 60227)

  • 1. Human sleep and 5-HTP. Effects of repeated high doses and of association with benserazide (RO.04.4602).
    Autret A; Minz M; Bussel B; Cathala HP; Castaigne P
    Electroencephalogr Clin Neurophysiol; 1976 Oct; 41(4):408-13. PubMed ID: 60227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a decarboxylase inhibitor (Ro 4-4602) on 5-HTP induced muricide blockade in rats.
    Bocknik SE; Kulkarni AS
    Neuropharmacology; 1974 Apr; 13(4):279-81. PubMed ID: 4546783
    [No Abstract]   [Full Text] [Related]  

  • 3. An unexpected effect of L-5 hydroxytryptophan-ethyl-ester combined with a peripheral decarboxylase inhibitor on human serum prolactin.
    van Praag HM; Korf J; Lequin RM
    Psychopharmacol Commun; 1976; 2(5-6):369-78. PubMed ID: 1088302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the discriminative stimulus properties of l-5-hydroxytryptophan in the presence of either citalopram or Ro 4-4602.
    Winter JC; Rabin RA
    Pharmacol Biochem Behav; 1988 Jul; 30(3):613-6. PubMed ID: 3264918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of 5-HTp reduction of ethanol drinking with the decarboxylase inhibitor, ro 4-4602.
    Geller I; Hartmann RJ; Messiha FS
    Pharmacol Biochem Behav; 1981 Dec; 15(6):871-4. PubMed ID: 6976579
    [No Abstract]   [Full Text] [Related]  

  • 6. Dose-dependent potentiation or inhibition by Ro4-4602 of 5-HTP hyperthermia in rabbits.
    Gardey-Levassort C; Lechat P
    J Pharm Pharmacol; 1974 Apr; 26(4):278-9. PubMed ID: 4151387
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of zimeldine and alaproclate combined with a small dose of 5-HTP on waking and sleep stages in cats.
    Sommerfelt L; Ursin R
    Behav Brain Res; 1987 Apr; 24(1):1-10. PubMed ID: 2953350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological influence on central serotonergic mechanisms in man and its consequences on sleep (author's transl)].
    Rüther E; Davis L; Papousek M; Reichinger M; Reiter H; Rudolph M
    Arzneimittelforschung; 1976; 26(6):1071-3. PubMed ID: 134732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a decarboxylase inhibitor on the Dopa and 5-HTP induced changes in the locomotor-like discharge pattern of rabbit hind limb nerves.
    Viala D; Buser P
    Psychopharmacologia; 1974; 40(3):225-33. PubMed ID: 4548539
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of administration of 5-hydroxytryptophan and an inhibitor of L-aromatic amino acid decarboxylase on glucose metabolism in rat brain.
    Wong KL; Tyce GM
    Neurochem Res; 1979 Apr; 4(2):277-87. PubMed ID: 313531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of the behavioral effects of 5-HTP by the decarboxylase inhibitor Ro 4-4602.
    Carter RB; Appel JB
    Pharmacol Biochem Behav; 1976 Apr; 4(4):407-9. PubMed ID: 935212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of firing of raphe neurones by tryptophan and 5-hydroxytryptophan: blockade by inhibiting serotonin synthesis with Ro-4-4602.
    Gallager DW; Aghajanian GK
    Neuropharmacology; 1976 Mar; 15(3):149-56. PubMed ID: 1084488
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of 5-hydroxytryptophan and L-tryptophan on wakefulness and sleep patterns in the cat.
    Ursin R
    Brain Res; 1976 Apr; 106(1):105-15. PubMed ID: 1083761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-5-hydroxytryptophan alone and in combination with a peripheral decarboxylase inhibitor in the treatment of depression.
    Zmilacher K; Battegay R; Gastpar M
    Neuropsychobiology; 1988; 20(1):28-35. PubMed ID: 3265988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of 5-hydroxytryptophan (5-HTP) in the regulation of the sleep/wake cycle in parachlorophenylalanine (p-CPA) pretreated rat: a multiple approach study.
    Touret M; Sarda N; Gharib A; Geffard M; Jouvet M
    Exp Brain Res; 1991; 86(1):117-24. PubMed ID: 1836762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 1-5 hydroxytryptophan infusion on growth hormone and prolactin secretion in man.
    Lancranjan I; Wirz-Justice A; Pühringer W; Del Pozo E
    J Clin Endocrinol Metab; 1977 Sep; 45(3):588-93. PubMed ID: 302840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-dopa plus dopa-decarboxylase inhibitor. Sleep organization in Parkinson's syndrome before and after treatment.
    Bergonzi P; Chiurulla C; Gambi D; Mennuni G; Pinto F
    Acta Neurol Belg; 1975; 75(1):5-10. PubMed ID: 1202895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between amphetamine and serotonergic agents on cat's isolated cerebral cortex.
    Vazquez AJ; Krip G
    Biol Psychiatry; 1973 Aug; 7(1):11-22. PubMed ID: 4270683
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence that taste aversion learning induced by l-5-hydroxytryptophan is mediated peripherally.
    Ervin GN; Carter RB; Webster EL; Moore SI; Cooper BR
    Pharmacol Biochem Behav; 1984 May; 20(5):799-802. PubMed ID: 6610880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation between the stimulus effects of l-5-hydroxytryptophan and LSD.
    Cunningham KA; Callahan PM; Appel JB
    Eur J Pharmacol; 1985 Jan; 108(2):179-86. PubMed ID: 3156756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.